Loading...
Entry LevelFull-time
Salary Range
$51,000 - $69,000 /year
This salary is estimated based on similar roles. The actual salary may vary.
About the Role
The Statistical Analyst plays a key role in pharmaceutical research and development, focusing on analyzing and reporting clinical trial data. This position involves both routine and complex activities, with supervision provided for more challenging tasks.
Key Responsibilities
- →Lead statistical programming activities for routine studies
- →Create documentation for regulatory filings including reviewers guides and data definition documents
- →Participate in the development of standard SAS Macros and present information on existing Macros
- →Perform exploratory data analyses and visualizations in collaboration with clinical pharmacologists or pharmacometricians
- →Produce dynamic and static data visualizations to communicate quantitative analyses
- →Develop SAS programs for the creation of ADaM data sets following CDISC standards
- →Develop SAS programs for the creation of Tables, Listings and Figures
- →Validate ADaM data sets, Tables, Listings and Figures
- →Create specifications for the structure of ADaM data sets for individual studies and integrated data
Requirements
- ✓Experience with statistical programming using SAS
- ✓Knowledge of ADaM and CDISC standards
- ✓Ability to perform exploratory data analyses and create visualizations
- ✓Experience with regulatory documentation and filings
- ✓Strong analytical and problem-solving skills
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
